BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of BioMarin Pharmaceutical Inc..
BioMarin Pharmaceutical Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of BioMarin Pharmaceutical Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of BioMarin Pharmaceutical Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of BioMarin Pharmaceutical Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of BioMarin Pharmaceutical Inc. and all latest updates of the company are provided.
The 2025 version of BioMarin Pharmaceutical Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 BioMarin Pharmaceutical Inc.- Key Facts
2.2 BioMarin Pharmaceutical Inc.- Geographic Locations
2.3 BioMarin Pharmaceutical Inc.- Subsidiaries and Affiliates
2.4 BioMarin Pharmaceutical Inc.- Business Divisions
2.5 BioMarin Pharmaceutical Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. BioMarin Pharmaceutical Inc. Strategic Analysis Review
3.1 BioMarin Pharmaceutical Inc.- Key Strategies
3.2 BioMarin Pharmaceutical Inc.- Company Outlook Statement
3.3 BioMarin Pharmaceutical Inc.- SWOT Analysis
3.3.1 BioMarin Pharmaceutical Inc.- Key Strengths
3.3.2 BioMarin Pharmaceutical Inc.- Key Weaknesses
3.3.3 BioMarin Pharmaceutical Inc.- Potential Opportunities
3.3.4 BioMarin Pharmaceutical Inc.- Potential Threats
3.4 BioMarin Pharmaceutical Inc.- Key Competitors
4. Business Description of the Company
4.1 BioMarin Pharmaceutical Inc.- Business Overview
4.2 BioMarin Pharmaceutical Inc.- Operations by Segment
5 Products and Services Details
5.1 BioMarin Pharmaceutical Inc.- Key Products
5.2 BioMarin Pharmaceutical Inc.- Key Service Areas
5.3 BioMarin Pharmaceutical Inc.- Key Brands
6 Company Developments
6.1 BioMarin Pharmaceutical Inc.- Company History
6.2 BioMarin Pharmaceutical Inc.- Latest Developments
7 Financial Analysis
7.1 BioMarin Pharmaceutical Inc.- Income Statements
7.2 BioMarin Pharmaceutical Inc.- Balance Sheet
7.3 BioMarin Pharmaceutical Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 BioMarin Pharmaceutical Inc.- Direct Competitors
8.2 BioMarin Pharmaceutical Inc.- Competitor Financial Ratios comparison
8.3 BioMarin Pharmaceutical Inc.- Competitor Stock Charts Comparison
8.4 BioMarin Pharmaceutical Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!